Last reviewed · How we verify
Indoximod base formulation
At a glance
| Generic name | Indoximod base formulation |
|---|---|
| Sponsor | NewLink Genetics Corporation |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Oral Bioavailability,and Food Effect Study and Single Ascending Dose PK Study in Healthy Male Volunteers (PHASE1)
- Single Ascending Dose PK, Oral Bioavailability and Food Effect Study in Healthy Male Volunteers (EARLY_PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Indoximod base formulation CI brief — competitive landscape report
- Indoximod base formulation updates RSS · CI watch RSS
- NewLink Genetics Corporation portfolio CI